BHC Bausch Health Companies
Bausch Health Companies earnings company data as of 7:06 PM ET 10/30
- 1 of 1 EPS beats
History
1 period, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 28 Oct | EPS | 1.08 | 1.15 | Beat +6.5% |
| Rev | $2.75B | $2.94B | Beat +6.7% |
Insider trades
Open-market buys and sales by BHC's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $15.6M bought by 1 insider
- None no sales outside a trading plan
- $507K sold by 3 insiders under 10b5-1 plans
-
Aimee J. Lenar President, US PharmaPlanned sale$259K 36,827 shares at $7.03 9.9% of stakeTraded Aug 19 Filed Aug 20
-
Frank D. Lee DirectorPlanned sale$133K 24,456 shares at $5.43 33% of stakeTraded May 19 Filed May 20
-
Seana Carson EVP, General CounselPlanned sale$65K 11,276 shares at $5.78 1.8% of stakeTraded Mar 2–3 Filed Mar 3
-
Seana Carson EVP, General CounselPlanned sale$50K 8,388 shares at $5.95 1% of stakeTraded Feb 27 Filed Feb 27
-
Paulson & Co. Inc. 10% ownerBuy$15.6M 2,500,000 shares at $6.25 +3.5% to stakeTraded Nov 25, 2025 Filed Nov 28, 2025
Also filed in the last 12 months, not counted as buying or selling: 28 stock grants, 12 share withholdings for taxes, and 2 other transactions.
SEC filings
Recent issuer filings from EDGAR, 11 shown.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.